Custom Search

Brand Name(s): Gemzar
CAS nº: 95058-81-4
(gem SIGH tah bean)

What is Gemcitabine?

Gemcitabine is a cancer (antineoplastic) medication. It acts by interfering with the growth of cancer cells and slows their growth and spread in the body.

This medicine is used to treat pancreatic cancer, particularly when it has metastasized, or spread to other parts of the body (Stage IVB). In combination with the drug cisplatin, gemcitabine is the first-line treatment for inoperable, metastasized non-small cell lung cancer.

Sometimes it is also used to treat cancers of the bladder or breast, or epithelial ovarian cancer.

Gemcitabine's brand name is Gemzar®.

See more Product Info

Latest News

SciClone Initiates Phase 2 Trial of RP101 in Late-Stage Pancreatic Cancer Patients

SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the first patient has been dosed...

[more]

Gemcitabine/Bevacizumab Plus Radiation Appear Active in Patients With Pancreatic Cancer: Presented at ASCO-GI

Doctors said that the combination of gemcitabine and bevacizumab along with radiation in the...

[more]

Conformal Radiation With Gemcitabine and Erlotinib Feasible in Unresected Pancreatic Cancer Patients: Presented at ASCO-GI

Patients with pancreatic cancer appear to tolerate the standard chemotherapy agent gemcitabine in...

[more]

Shilpa cancer drugs get Korean nod

Raichur, Karnataka-based Shilpa Medicare has got South Korean Food and Drug Administration (KFDA)...

[more]

Gemzar® plus Second Chemotherapy Agent Provides Small Survival Benefits in Advanced Pancreatic Cancer

According to results recently published in the journal Drugs and Aging, the combination of Gemzar®...

[more]

Use of this site is subject to the following terms of use